Mirum Pharmaceuticals, Inc. MIRM Accrued expenses and other current liabilities
Accrued expenses and other current liabilities at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:AccruedLiabilitiesAndOtherLiabilitiesCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued expenses and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s accrued expenses and other current liabilities?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accrued expenses and other current liabilities of $187.63M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s accrued expenses and other current liabilities changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accrued expenses and other current liabilities increased by 61.8% year-over-year, from $115.94M to $187.63M.
- What does accrued expenses and other current liabilities mean?
- This represents the aggregate of short-term obligations that have been incurred but not yet invoiced or paid, including items such as accrued compensation, professional fees, and other operational expenses. It serves as a measure of the company's immediate financial commitments to third parties for services or goods already received. Monitoring this balance helps investors assess the company's short-term liquidity requirements and the timing of cash outflows for operational support.